Kimberly Lee | Senior Vice President, Corporate Communications and Investor Relations |
RA Session II | President, Chief Executive Officer and Founder |
Suyash Prasad | Chief Medical Officer and Head, R&D |
Kamran Alam | Chief Financial Officer |
Elizabeth Webster | Goldman Sachs |
Joon Lee | Truist Securities |
Laura Chico | Wedbush Securities |
Gil Blum | Needham & Company |
Eun Yang | Jefferies |
Raju Prasad | William Blair |
Yun Zhong | BTIG |
Mike Ulz | Morgan Stanley |
Kristen Kluska | Cantor Fitzgerald |
Welcome to the Taysha Gene Therapies Second Quarter 2021 Financial Results and Corporate Update Conference Call. [Operator Instructions] As a reminder, this call is being recorded today, August 16, 2021. I will now turn the call over to Dr. Kimberly Lee, Senior Vice President of Corporate Communications and Investor Relations. Please go ahead.